Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
Our aim was to evaluate liver transplant outcomes involving donors with high macrosteatosis grafts in the obese modern liver transplant recipient population. A high-steatosis graft was defined as donor graft macrosteatosis ≥ 30% on biopsy. Recipient obesity was defined as body mass index (BMI) > 35 adjusted for ascites. Raw and adjusted recipient liver transplant survival were evaluated and compared between four cohorts: 1) High-steatosis graft in high-BMI recipient, 2) Low-steatosis graft in high-BMI recipient, 3) High-steatosis graft in normal-BMI recipient, 4) Low-steatosis graft in normal-BMI recipient. After adjustment for multiple factors, recipient high-BMI remained an independent predictor of post-transplant mortality at 30 days (p<0.0001) and persisted at one year (p=0.009). A high-steatosis graft was the strongest independent predictor of mortality at 30 days (HR 2.05, 1.66-2.53, p<0.0001) and that effect was diminished but persistent at one year (1.27, 1.10-1.46, p=0.001). Recipient high-BMI and a high-steatosis graft are both significant independent and equally powerful predictors of mortality after modern liver transplant. High-steatosis grafts transplanted into obese recipients have the highest mortality. The increase in mortality associated with a high-steatosis graft into a normal-BMI recipient is similar in magnitude to a low-steatosis graft placed into a high-BMI recipient.